Evernorth Puts $100M Behind an AI Rewrite of Specialty Pharmacy

Evernorth, the health services arm of The Cigna Group, launched a $100 million AI-powered specialty pharmacy program on July 1 called Pharmacy Forward, with the goal of cutting clinician paperwork in half and halving the time it takes patients to start a complex medication. The investment runs through 2028 and lands first at Accredo Specialty Pharmacy, the Evernorth brand that serves more than one million patients with chronic and complex conditions each year. Evernorth expects the program to generate approximately $400 million in value by the end of 2028.

Pharmacy Forward puts AI into the four slowest steps of specialty pharmacy: clinical care, prescription intake, administration, and medication fulfillment. Evernorth’s pharmacy and care delivery president Matt Perlberg called it a commitment to meet patients where they are. The bet is that shaving friction at every step will pay back roughly four times what the company is putting in.

The $100 Million Bet Evernorth Just Placed

Evernorth unveiled Pharmacy Forward from Bloomfield, Connecticut on Wednesday, July 1, 2026, framing it as an AI rebuild of how specialty drugs reach the patients who need them. The program carries a $100 million investment through 2028, its first deployment at Accredo Specialty Pharmacy, and a long list of measurable targets that range from clinician paperwork to medication shipping times. Evernorth plans to extend the same capabilities to its other pharmacy operations in coming years, which include Express Scripts and Express Scripts Pharmacy. The full announcement is on Evernorth’s announcement of the Pharmacy Forward program.

Evernorth is the pharmacy, care, and benefits solutions division of The Cigna Group (NYSE: CI), with more than 40,000 employees serving 190 million people, according to its own announcement. Accredo runs through Therapeutic Resource Centers, condition-specific teams built around the chronic and complex diseases it covers. Other Evernorth brands include eviCore and MD Live.

Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, including Accredo, and Executive Vice President of Customer Innovation for The Cigna Group, said Pharmacy Forward is meant to make specialty care feel like an AI-enabled concierge instead of a paperwork queue.

“Patients navigating complex health conditions need comprehensive, expert support, often during some of the most difficult moments in their lives. Pharmacy Forward reflects our commitment to meet patients where they are, delivering an even faster, more seamless experience while ensuring they receive the personalized support and clinical care they deserve.”

Perlberg also serves as Executive Vice President of Customer Innovation for The Cigna Group. The Cigna Group trades on the NYSE under the ticker CI.

Four AI Levers Pulled At Once

Evernorth describes Pharmacy Forward as applying AI across four core areas: clinical care, prescription intake, administration, and medication fulfillment. The structure is deliberate. Each step in the specialty pharmacy chain gets a separate AI use case, with named targets attached.

The announcement breaks the four down with examples for each. Care Enablement uses AI-generated summaries and predictive analytics so clinicians can flag patients at risk of falling off therapy. Experience Accelerators include AI-enabled scheduling that calls patients during their preferred windows. Rx Readiness speeds up prior authorizations and copay assistance. One Fulfillment Network analyzes patient location, delivery timing, and medication handling to pick the right dispensing site.

Each lever has a number attached, and the numbers are Evernorth’s own forecasts rather than third-party estimates.

Cutting Clinician Paperwork In Half

The biggest single number in the announcement is the 50% reduction in clinician documentation time that Evernorth expects Pharmacy Forward to deliver. Documentation is one of the most visible bottlenecks in specialty pharmacy, where clinicians spend significant time translating prescriptions into forms and notes that other systems can read. Perlberg has tied that paperwork reduction to the same Care Enablement layer that drives predictive analytics, meaning the two targets share infrastructure.

Perlberg told MedCity News that about 15% of Evernorth clinicians’ time goes to administrative tasks. Cutting that share is part of the program’s pitch.

Care Enablement is the AI lever the documentation number rides on. It bundles AI-generated summaries of patient history with predictive analytics that flag patients likely to fall off therapy or experience adverse events. Clinicians can then spend the saved time on direct patient support rather than chart assembly.

Adherence is the second measurable target, and Evernorth ties it to the same Care Enablement layer. The company expects Pharmacy Forward to push medication adherence beyond the 80% mark that the industry treats as standard.

Halving The Wait For A Specialty Medication

Rx Readiness is the lever that attacks the time-to-medication clock. Pharmacy Forward uses AI to tighten prior authorization submissions, surface copay assistance eligibility, and make sure prescriptions are ready earlier in the process. Evernorth says the program is cutting the time from prescription receipt to patient delivery in half.

The patient-facing piece is Experience Accelerators. Accredo has already deployed AI-enabled scheduling that calls patients during their preferred windows. The company expects a 25% increase in use of personalized patient digital pathways, the mobile-app and website flows that let patients confirm routine steps on their own.

The combined goal is for specialty drugs to feel like a process patients navigate instead of one they survive. Perlberg framed the entire program around giving patients their time back at the moment they are sickest, with the expectation that Evernorth’s other pharmacy brands pick up similar capabilities over time.

A Network Built For Next-Day Ground Shipping

Pharmacy Forward does not stop at the prescription pad. Evernorth is also expanding capacity, staffing, and capabilities across Accredo’s nearly 40 care facilities in the United States. The stated target: 90% of patients within a 1-day or same-day ground shipping radius for complex specialty medications. AI sits behind that shipping promise too, continuously analyzing patient location, delivery timing, and medication handling requirements to choose the most effective dispensing site for each prescription. The shipping expansion is meant to reduce reliance on long ground hauls and air shipments, both of which are vulnerable to weather delays.

The market context frames why speed matters. The global chronic disease management market grew from $6.9 billion in 2025 to a projected $18.8 billion in 2034, per chronic disease management market projections through 2034. The US median age climbed from 39.2 in 2024 to 39.4 in 2025, per the US Census Bureau, and the same coverage notes a growing patient pool for chronic and specialty conditions. Evernorth expects Pharmacy Forward to extend to its other pharmacy operations in the coming years.

Why The Stakes Are Bigger Than The Headline Number

Evernorth’s forecast for Pharmacy Forward is approximately $400 million in value by the end of 2028. The implied return on the investment is roughly four to one, and it depends on every one of the four AI levers landing close to its stated target.

The reason a $100 million bet is even on the table is the size of the specialty drug category. Specialty drugs already account for well more than half of total prescription spending across health plans, employers, and government programs. Benefits consultants say specialty costs run at 60% or more of total drug spending for many employer clients, driven heavily by anti-obesity GLP-1 medicines, per specialty drug share of US prescription spending.

“AI is enabling us to fundamentally reimagine how we support each patient’s journey. By responsibly combining real-time data, advanced analytics and deep clinical expertise, we can deliver more personalized, proactive support, helping people access the care they need faster and achieve better health outcomes.”

Katya Andresen, Chief Data, Digital and AI Officer at The Cigna Group, made that case on the same day Evernorth unveiled the program. Evernorth says it will measure the program’s success by medication adherence, patient net promoter score, and time-to-medication, three KPIs the company will track publicly and internally. The forecasts carry risk. Evernorth has set specific targets for adherence, documentation, shipping, and digital pathway adoption, and any miss on those targets cuts into the projected $400 million value.

Frequently Asked Questions

What is Evernorth’s Pharmacy Forward program?

Pharmacy Forward is an AI-powered specialty pharmacy program unveiled by Evernorth on July 1, 2026. It applies artificial intelligence across four areas: clinical care, prescription intake, administration, and medication fulfillment. The program is backed by a $100 million investment through 2028.

How much is Evernorth investing in Pharmacy Forward?

Evernorth is committing $100 million through 2028 to build and deploy Pharmacy Forward. The company expects the program to generate approximately $400 million in value by the end of 2028.

Which Evernorth brand launches Pharmacy Forward first?

Pharmacy Forward launches first at Accredo Specialty Pharmacy, which serves more than one million patients per year with chronic and complex conditions through its Therapeutic Resource Centers. Evernorth plans to extend the capabilities to its other pharmacy operations in coming years.

What does Pharmacy Forward aim to do?

Evernorth’s stated targets include reducing clinician documentation time by up to 50%, cutting time from prescription receipt to medication delivery in half, improving medication adherence beyond the 80% industry standard, and putting 90% of patients within a 1-day or same-day ground shipping radius. Accredo also expects a 25% increase in personalized digital pathway use.

When did Evernorth announce Pharmacy Forward?

Evernorth unveiled Pharmacy Forward on July 1, 2026, from its headquarters in Bloomfield, Connecticut. The Cigna Group, the parent company, trades on the NYSE under the ticker CI.

Disclaimer: This article discusses a corporate AI investment in specialty pharmacy and is for informational purposes only. It is not medical, investment, or legal advice. Figures and forecasts reflect Evernorth’s own announcements as of July 1, 2026 and may change.